drugset / Trial / NCT02385422

The Effect of Carvedilol Vs Propranolol in Cirrhotic Patients With Variceal Bleeding

NCT02385422

Phase 4 Unknown 480 enrolled Shanghai Zhongshan Hospital
RandomizedParallel-groupOpen-labelPrevention

Summary

To compare the efficacy and safety of Carvedilol and Propranolol in patients with cirrhosis-related esophagogastric varices after multiple endoscopic treatments for secondary prophylaxis.

Timeline

Start
2015-03
Primary completion
2017-06
Completion
2017-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Carvedilol Other / unclassified 25 mg Oral
Comparator Propranolol Small molecule 160 mg Oral